ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
66 hedge funds and large institutions have $77M invested in Zynerba Pharmaceuticals, Inc in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
41% less call options, than puts
Call options by funds: $17.1M | Put options by funds: $28.8M
Holders
66
Holding in Top 10
–
Calls
$17.1M
Puts
$28.8M
Top Buyers
| 1 | +$7.83M | |
| 2 | +$5.53M | |
| 3 | +$5.14M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.79M |
| 5 |
Citigroup
New York
|
+$3.73M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$5.05M | |
| 3 | -$2.01M | |
| 4 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
-$1.65M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.3M |